Revlimid approved for multiple myelomaCelgene's Revlimid (lenalidomide 15 mg and 25 mg capsules) is now indicated for the treatment of multiple myeloma (in combination with dexamethasone) in patients who have received at least one prior therapy. Many U.K. pharmacy workers giving bad adviceMany U.K. pharmacy workers giving bad advice Health organizations join hands to promote safe medication use CPhA, CMA join forces with Rx&D to promote safe and appropriate medication use among Canadians. New indication for Viread Gilead Sciences' Viread (tenofovir disoproxil fumarate tablets) is now indicated for the treatment of chronic hepatitis B infection in adults. Air travel during pregnancy Air travel during pregnancy has not been shown to increase the rate of miscarriage in pregnant women, according to the Motherisk Program at Toronto's Hospital for Sick Children. A Question of Ethics Can pharmacy accommodate differing principles? Practice Issues: Adverse Reactions Studies look at cardiovascular effects of glitazones and adverse drug events in the elderly. Alberta defines acceptable e-scripts Colleges stress need for suitable infrastructure. Colorecetal cancer Early detection, treatment and management of side effects. Drug News: October 2008 Zeftera (ceftobiprole medocaril for injection, 500 mg/vial), Janssen-Ortho. Ont. survey shows painkiller addiction growing concern Team-based approach to treatment could help. Practice Issues: Adverse reactions - ACEI- and ARB-induced angioedema Angioedema is a self-limiting, nonpitting edema that occurs in the skin and mucous membranes. First Previous 2097 2098 2099 2100 2101 Next Last
